Navigating the New Psoriasis Guidelines: Implications for Clinical Practice is organized by CME Outfitters, LLC.
Premiere Date: Thursday, March 26, 2020
Credit Expiration Date: Friday, March 26, 2021
CME Credit (Physicians):
CME Outfitters, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs).
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ABP MOC Credit:
Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1.5 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
Statement of Need:
The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have recently released new joint guidelines that outline best practices for the management of psoriasis (PsO) with biologics, the need for awareness and attention to comorbidities, and guidelines for pediatric PsO treatment. Clinicians must ensure that they are aware of these guidelines and of strategies to incorporate them into clinical practice, including the integration of biologic therapy into treatment plans, the implementation of strategies to manage comorbidities, and the management of pediatric patients with PsO, in alignment with guideline recommendations.
In this interactive CMEO Live and On Demand webcast, leading experts in PsO will utilize clinical cases to illustrate real-life approaches that learners can apply in order to optimize incorporation of these latest recommendations into clinical practice.
At the end of this CE activity, participants should be able to:
• Integrate biologic therapy into treatment plans for appropriate patients with moderate-to-severe PsO, in accordance with the joint AAD-NPF guidelines.
• Implement strategies to manage comorbidities in patients with PsO as recommended by the joint AAD-NPF guidelines.
• Apply the joint AAD-NPF guidelines when managing pediatric patients with PsO.
The following learning objectives pertain only to those requesting CNE or CPE credit:
• Describe treatment plans for appropriate patients with moderate-to-severe PsO in accordance with the joint AAD-NPF guidelines.
• Explain strategies to manage comorbidities in patients with PsO, as recommended by the joint AAD-NPF guidelines.
• Identify the joint AAD-NPF guidelines when managing pediatric patients with PsO.
Dermatologists, primary care physicians, physician assistants, nurse practitioners, nurses, and pharmacists.